Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...

CAMBRIDGE, Mass., Nov. 13 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that it has received a letter from the U.S. Food and Drug Administration requesting ...

Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...

(Recasts first paragraph; adds Genzyme comments, sales figures, competitors, byline; updates stock price) By Lisa Richwine GAITHERSBURG, Md., Dec 9 (Reuters) - A U.S. advisory panel has unanimously ...

To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...

Please provide your email address to receive an email when new articles are posted on . Sanofi has issued a limited voluntary recall of its Synvisc-One, an injected gel for treating arthritis, due to ...

BOSTON, Feb 26 (Reuters) - Genzyme Corp said on Thursday it has won European approval to make its drug Myozyme at a 4,000-liter manufacturing facility, expanding supply for patients with the rare ...

osteoarthritis pain drug Synvisc from Wyeth. The transaction is expected to close in January. Under the terms of the agreement, Genzyme will pay Wyeth up-front payments of $121 million in cash for the ...